Atlas Trials

Medesis Pharma SA

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Medesis Pharma SA

RecordFirmDate
Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease (NCT05423522)Medesis Pharma SA2022-05-20
NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19) (NCT05451654)Medesis Pharma SA2022-02-04

Track Medesis Pharma SA automatically

Every clearance here is in the API, with alerts when new ones post.